AU7684500A - Lpl potentiators - Google Patents

Lpl potentiators

Info

Publication number
AU7684500A
AU7684500A AU76845/00A AU7684500A AU7684500A AU 7684500 A AU7684500 A AU 7684500A AU 76845/00 A AU76845/00 A AU 76845/00A AU 7684500 A AU7684500 A AU 7684500A AU 7684500 A AU7684500 A AU 7684500A
Authority
AU
Australia
Prior art keywords
potentiators
lpl
lpl potentiators
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76845/00A
Inventor
Noriaki Hamakawa
Takahisa Motomura
Hisashi Shinkai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Tobacco Inc
Original Assignee
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc
Publication of AU7684500A publication Critical patent/AU7684500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57—Aryl or substituted aryl radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AU76845/00A 1999-10-12 2000-10-12 Lpl potentiators Abandoned AU7684500A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP28918799 1999-10-12
JP11/289187 1999-10-12
JP35164599 1999-12-10
JP11/351645 1999-12-10
JP2000/304587 2000-10-04
JP2000304587A JP2001226358A (en) 1999-10-12 2000-10-04 Lpl potentiator
PCT/JP2000/007072 WO2001027088A1 (en) 1999-10-12 2000-10-12 Lpl potentiators

Publications (1)

Publication Number Publication Date
AU7684500A true AU7684500A (en) 2001-04-23

Family

ID=27337496

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76845/00A Abandoned AU7684500A (en) 1999-10-12 2000-10-12 Lpl potentiators

Country Status (3)

Country Link
JP (1) JP2001226358A (en)
AU (1) AU7684500A (en)
WO (1) WO2001027088A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002060374A2 (en) * 2001-01-29 2002-08-08 Insight Strategy And Marketing Ltd Benz-1,3-azole derivatives and their uses as heparanase inhibitors
DK1587821T3 (en) 2002-12-19 2008-11-10 Scripps Research Inst Compositions and Methods for Stabilizing Transthyretin and Inhibiting Transthyretin Failure
US7868033B2 (en) 2004-05-20 2011-01-11 Foldrx Pharmaceuticals, Inc. Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
US20090281120A1 (en) * 2005-12-12 2009-11-12 Ono Pharmaceutical Co., Ltd Bicyclic heterocyclic compound
AR061185A1 (en) 2006-05-26 2008-08-13 Chugai Pharmaceutical Co Ltd HETEROCICLICAL COMPOUNDS AS INHIBITORS OF HSP90. PHARMACEUTICAL COMPOSITIONS.
RU2009136343A (en) 2007-03-01 2011-04-10 Чугаи Сейяку Кабусики Кайся (Jp) MACROCYCLIC COMPOUND
BRPI0822685A2 (en) * 2008-05-14 2015-06-30 Otsuka Pharma Co Ltd Lipoprotein lipase activation compositions comprising benzene derivatives
JP5540227B2 (en) * 2009-02-04 2014-07-02 株式会社大塚製薬工場 Phenylimidazole compound
US9249112B2 (en) 2011-09-16 2016-02-02 Pfizer Inc. Solid forms of a transthyretin dissociation inhibitor
CN106946710B (en) * 2017-04-13 2019-05-17 安徽广信农化股份有限公司 A kind of synthesis technology of oxadiazon Intermediate nitro phenol
CN107915570B (en) * 2017-12-06 2020-09-22 金凯(辽宁)化工有限公司 Preparation method of 4-bromo-1-methyl-2- (trifluoromethyl) benzene
CN110713441B (en) * 2019-10-25 2023-03-10 湖南兴同化学科技有限公司 Synthetic method of oxadiazon intermediate 2, 4-dichloro-5-nitrophenol
CN112321513B (en) * 2020-11-06 2022-12-23 药康众拓(江苏)医药科技有限公司 Heterocyclic compound and preparation method and application thereof
AU2022317251A1 (en) * 2021-07-29 2024-03-14 Merck Patent Gmbh Srpk inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4714762A (en) * 1986-10-31 1987-12-22 Warner-Lambert Company Antiarteriosclerotic substituted benzimidazol-2-yl-and 3H-imidazo[4,5-b]pyridin-2-yl-phenoxy-alkanoic acids and salts and esters thereof
JP2584336B2 (en) * 1989-05-30 1997-02-26 株式会社大塚製薬工場 Carboxamide derivatives

Also Published As

Publication number Publication date
WO2001027088A1 (en) 2001-04-19
JP2001226358A (en) 2001-08-21

Similar Documents

Publication Publication Date Title
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU5285200A (en) Reliable multi-unicast
AU7684500A (en) Lpl potentiators
AU5967600A (en) Candystraw
AU7514700A (en) Cyanopiperidines
AU4115400A (en) Short-circuiter
AU6335000A (en) Depthimeter
AU2804600A (en) Arylaminoalkylamides
AU2023701A (en) Sketcher
AU6440900A (en) Homogentisate-dioxygenase
AU2699800A (en) Organoceramics
AU4568900A (en) Improved can
AU6098300A (en) Follistatin-3
AU4916900A (en) Benzofuranylsulfonates
AU4561600A (en) Benzofuranylaminoalcohols
AU1901801A (en) Glucofuranoses
AU1915601A (en) Periotome
AU2582200A (en) Windturbine
AU7303400A (en) Osseo-distractor
AU7513400A (en) Hydantoin-racemase
AU4435300A (en) Hula-hoop
AU2197301A (en) Microlamp
AU5416100A (en) Retinoscopes
AU7567500A (en) Duckboard

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase